Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$98.2M Sell
917,596
-85,000
-8% -$9.35M 1.38% 4
2026
Q1
$105M Buy
1,002,596
+200,000
+25% +$23.5M 1.83% 4
2025
Q4
$100M Buy
802,596
+17,300
+2% +$2.06M 1.64% 3
2025
Q3
$94.2M Sell
785,296
-45,000
-5% -$4.75M 1.28% 7
2025
Q2
$76.2M Buy
830,296
+171,403
+26% +$15.6M 1.28% 13
2025
Q1
$58M Buy
658,893
+4,000
+0.6% +$393K 1.15% 21
2024
Q4
$60.6M Sell
654,893
-178,536
-21% -$17.2M 1.44% 13
2024
Q3
$77.3M Buy
833,429
+115,000
+16% +$9.66M 1.37% 10
2024
Q2
$53.9M Buy
718,429
+193,429
+37% +$15.4M 1.08% 24
2024
Q1
$45.3M Buy
525,000
+115,000
+28% +$8.79M 0.94% 25
2023
Q4
$28.4M Buy
410,000
+315,000
+332% +$19M 0.72% 39
2023
Q3
$5.2M Buy
+95,000
New +$5.4M 0.15% 156

Other funds holding CRH

Scopus Asset Management's CRH Position: Q2 2026 in Review

Scopus Asset Management reduced its CRH (CRH) stake by 8.5% in Q2 2026, selling an estimated $9.35M and leaving 917,596 shares worth $98.2M. The position accounts for 1.38% of the portfolio, ranked #4.

Scopus Asset Management first reported a position in CRH in Q3 2023 and has held it in 12 quarters since. The position peaked at $105M in Q1 2026. 1,023 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Scopus Asset Management held 917,596 shares of CRH worth $98.2M as of Q2 2026.
  • Scopus Asset Management sold 85,000 CRH shares in Q2 2026, an estimated $9.35M.
  • CRH made up 1.38% of Scopus Asset Management's portfolio in Q2 2026, its #4 holding.
  • Scopus Asset Management first reported a position in CRH in Q3 2023 and has held it in 12 quarters since.
  • Scopus Asset Management's CRH position peaked at $105M in Q1 2026.
  • 1,023 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Scopus Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.